A Study Comparing the Efficacy and Safety of Vanucizumab and FOLFOX With Bevacizumab and FOLFOX in Participants With Untreated Metastatic Colorectal Cancer
Clinical trial NCT02141295 · TERMINATED
Trial details
- NCT number
- NCT02141295
- Sponsor
- Hoffmann-La Roche
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2014-06-30
- Primary completion
- 2016-07-29
- Enrollment
- 197
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.